Outpatient Service for Mid-trimester Termination of Pregnancy
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This study seeks to evaluate the safety, acceptability and feasibility of an outpatient "day
procedure" for medical abortion at 13-18 weeks gestation. The study regimen will consist of a
single dose of 200 mg mifepristone to be taken orally either at home or at the hospital,
followed approximately 24 - 48 hours later with administration of 400 mcg misoprostol. Repeat
doses of 400 mcg (two tablets) of misoprostol will be administered buccally every three hours
until the abortion is achieved.
Phase:
Phase 4
Details
Lead Sponsor:
Gynuity Health Projects
Collaborators:
Center for Research on Environment, Health and Population Activities CREHPA Kathmandu Medical College Kathmandu Medical College and Teaching Hospital Kathmandu Model Hospital KIST Medical College KIST Medical College, Teaching Hospital